Skip to content
OpenCapital
Get started
CHE

Chemed (CHE) Q1 2026 Earnings

CHE·Reported April 23, 2026·After market close

Chemed reported Q1 2026 revenue of $657.5M (+1.6% YoY), beat analyst consensus of $649.8M by $7.7M. Diluted EPS came in at $5.65 (+0.4% YoY), beat the $5.30 consensus by $0.35.

Revenue
$657.5Mbeat by $7.7M
Consensus: $649.8M
Diluted EPS
$5.65beat by $0.35
Consensus: $5.30
SEC

SEC Filings

Earnings release8-K · 0000019584-26-000010
Quarterly report10-Q · 0000019584-26-000012

Financial Snapshot

Trailing eight quarters through Q1 2026

View all metrics

Q1 2026 Earnings FAQ

Common questions about Chemed's Q1 2026 earnings report.

Chemed (CHE) reported Q1 2026 earnings on April 23, 2026 after market close.

Chemed reported revenue of $657.5M and diluted EPS of $5.65 for Q1 2026.

Revenue beat the consensus estimate of $649.8M by $7.7M. EPS beat the consensus estimate of $5.30 by $0.35.

Compared to the same quarter a year prior, revenue grew 1.6% from $646.9M a year earlier and diluted EPS grew 0.4% from $5.63.

You can read the 8-K earnings release (0000019584-26-000010) and the 10-Q periodic report (0000019584-26-000012) directly on SEC EDGAR. The filing index links above go to sec.gov.